Clinical Trial Update: Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial compared Biphasic Human Insulin 30 with Biphasic Insulin Aspart in subjects with diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic Human Insulin 30 (biphasic human insulin 30)
• Biphasic insulin aspart

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED